Johnson & Johnson MedTech

Reimagining the future of surgical robotics

OTTAVA system and the future of surgical experience.

During 2023, I had the amazing opportunity to spend 6 months with J&J in the Santa Clara office. As an Industrial Design Co-Op for the OTTAVA robotic surgical system, I worked on everything from cross-functional stakeholder collaboration, user research/testing, design systems, and developing prototypes with multiple prototyping tools. Working alongside a team of talented designers, researchers, engineers, Project Managers, and surgeons throughout this experience helping cultivate my skills and knowledge as a ID Designer.

The OTTAVA™ System is designed to transform the surgical experience with innovative architecture, clinically relevant features, and trusted Ethicon instrumentation; Johnson & Johnson MedTech anticipates 2024 FDA Submission to Initiate U.S. Clinical Trials

Please contact me for more information about this Co-Op Project Experience!

JNJ Updates / Releases

Nov. 7, 2023 – New Brunswick, New Jersey – Johnson & Johnson MedTech* today announced plans to submit the OTTAVA robotic surgical system for an investigational device exemption (IDE) application to the U.S. Food & Drug Administration (FDA) in the second half of 2024 to initiate clinical trials. Drawing on Johnson & Johnson MedTech’s more than 135-year legacy of leadership in surgery, OTTAVA reimagines the surgical experience. The system is designed to create space in the operating room (OR), simplify complex workflows, enable flexibility for clinical approaches, and deliver the trusted performance of Ethicon** instrumentation.